on ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE)
OSE Immunotherapeutics to Hold Annual General Meeting on June 24, 2026
Nantes, France - OSE Immunotherapeutics SA announced the scheduling of its Annual General Meeting on June 24, 2026, at 10:00 am CET. The meeting is set to occur at Jones Day's offices in Paris, France, with an option for shareholders to join via a live webcast on the company's website.
An agenda and draft resolutions for the meeting were published on May 20, 2026, in French BALO. A notice containing further details will follow on June 8, 2026. Shareholders can access preparatory documents on OSE Immunotherapeutics’ website or request them via email, provided proof of shareholder status is furnished.
These steps are in alignment with French Commercial Code articles ensuring transparency and accessibility to information imperative for shareholder engagement.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ORPHAN SYNERGY EUROPE-PHARMA news